(Q28473504)

English

CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer

scientific article

Statements

CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Bjørn Østenstad
0 references
Elisabet O Berge
0 references
Terje Risberg
0 references
Lovise Maehle
0 references
Lars Fredrik Engebretsen
0 references
26 August 2008
0 references
0 references
3
0 references
8
0 references
e3062
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit